Article

Bausch + Lomb introduces new logo, icon

Bausch + Lomb has unveiled a redesigned company logo and icon. Both incorporate hues of the company?s traditional blue and green colors and introduce the plus symbol instead of the ampersand.



Rochester, NY

-Bausch + Lomb has unveiled a redesigned company logo and icon. Both incorporate hues of the company’s traditional blue and green colors and introduce the plus symbol instead of the ampersand.

“Our new corporate identity reflects the ongoing evolution of Bausch + Lomb as we make strides in growing our business for the benefit of medical practitioners, retail partners, consumers, and patients around the world,” said Gerald M. Ostrov, the company’s chairman and chief executive officer.

“Based on our strong momentum coming out of last year, as well as a number of planned new product launches and market initiatives over the coming months, we believe that 2010 will be a banner year for the company and the millions of people we’re so fortunate to serve each year,” Ostrov added.

The company will phase in the new logo and icon over time. It will co-exist with the former “pathways” logo for the next 18 to 24 months as product packaging and other materials are updated.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.